Summary
Proliferating cell nuclear antigen (PCNA) is a 36-kDa DNA polymerase-σ auxiliary protein which accumulates in the nucleus during S phase of the cell cycle. Immunohistochemical labeling indices (LI) of PCNA and Ki-67 were compared using an avidin-biotin complex method on frozen sections of 27 nervous system tumors, 3 normal cerebral cortices, and 3 peripheral nerves. In glial tumors, PCNA and Ki-67 LI increased with increasing tumor grade (Daumas-Duport system). In 5 low-grade glial tumors, PCNA and Ki-67 LI were ≤1%, except for one optic nerve glioma (Ki-67 LI=6%). In 7 grade 3 astrocytomas, and 1 mixed glioma, PCNA LI were ≤1–1.5%, while Ki-67 LI were 2%–10%. In 7 grade 4 astrocytomas and 1 metastatic carcinoma, PCNA LI ranged from 6%–15% while Ki-67 LI ranged from 17%–30%. In 5 of 6 schwannomas, focally high PCNA LI (4%–65%) were noted, despite low LI with Ki-67 (≤1.6%). Scattered normal schwann cell nuclei also stained with PCNA, but normal cerebral cortex did not. These data suggest that: (1) in higher-grade gliomas, PCNA may be a more specific S-phase marker, although a less sensitive proliferation marker, than Ki-67; (2) PCNA LI do not distinguish low-grade gliomas from grade 3 astrocytomas; (3) in schwannomas, PCNA may not reflect proliferative activity since it seems to react with an epitope present in normal schwann cells; and (4) the variable PCNA staining pattern introduces greater difficulties in cell counting than with Ki-67. These factors may limit the use of this anti-PCNA antibody in evaluating nervous system tumors.
Similar content being viewed by others
References
Bravo R (1986) Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp Cell Res 163:287–2993
Bravo R, Frank R, Blundell PA, MacDonald-Bravo H (1987) Cyclin/PCNA is the auxiliary protein of DNA-polymerase delta. Nature 326:515–517
Burger PC (1989) The grading of astrocytomas and oligodendrogliomas. In: Fields WS (ed) Brain tumors:a review of histologic classification. Springer-Verlag, New York, pp 171–180
Burger PC, Shibata T, Kleihues P (1986) The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 10:611–617
Celis JE, Celis A (1985) Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA 82:3262–3266
Daumas-Duport C, Scheithauer BW, O'Fallon J, Kelly P (1988) Grading of astrocytomas: a simple and reproducible method. Cancer 62:2152–2165
Galand P, Degraef C (1989) Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S-phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 22:383–392
Garcia RL, Coltrera MD, Gown AM (1989) Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded fittues. Am J Pathol 134:733–7399
Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31:13–20
Gerdes J, Lemke H, Baisch H, Walker H-H, Schwab U, Stein H (1984) Cell-cycle analysis of a cell proliferation-associated nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710–1715
Kim TS, Halliday AL, Hedley-Whyte ET, Convery K (1991) Correlates of survival and the Daumas-Duport grading system for astrocytomas. J Neurosurg 74:27–37
Miyachi K, Fritzler MJ, Tan EM (1978) Autoantibody to a nuclear antigen in proliferating cells. J Immunol 121:2228
Morimura T, Kitz K, Budka H (1989) In situ analysis of cell kinetics in brain tumors. Acta Neuropathol 77:276–282
Nishizaki T Orita T, Furutani Y, Ikeyama Y, Aoki H, Sasaki K (1989) Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labeling indices in human brain tumors. J Neurosurg 70:379–384
Ogata K, Kurki P, Celis JE, Nakamura RM, Tan EM (1987) Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp Cell Res 168:475–486
Pardee AB (1989) G1 events and regulation of cell proliferation. Science 246:603–608
Raghavan R, Steart PV, Weller RO (1990) Cell proliferation in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: a Ki-67 study. Neuropathol Appl Neurobiol 16:123–133
Robbins BA, de la Vega D, Ogata K, Tan EM, Nakamura RM (1987) Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med 111:841–845
Shibata T, Burger PC (1987) The use of the monoclonal antibody Ki-67 in determination of the growth fraction in pediatric brain tumors. Child's Nervous Syst 3:364–367
Smetana K, Gyorkey F, Chan P-K, Tan E, Busch H (1983) Proliferating cell nuclear antigen (PCNA) and human malignant tumor nucleolar antigens (HMTNA) in nucleoli of human hematological malignancies. Blut 46:133–141
Tabuchi K, Honda C, Nakane PK (1987) Demonstration of proliferating cell nuclear antigen (PCNA/cyclin) in glioma cells. Neurol Med Chir (Tokyo) 27:1–5
Author information
Authors and Affiliations
Additional information
Supported in part by an American Cancer Society Career Development Award (ADT). Presented in part at the 66th meeting of the American Association of Neuropathologists, San Francisco, CA, June 14, 1990
Rights and permissions
About this article
Cite this article
Louis, D.N., Edgerton, S., Thor, A.D. et al. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study. Acta Neuropathol 81, 675–679 (1991). https://doi.org/10.1007/BF00296379
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00296379